Skip to main content
Clinical Trials/IRCT2014053016465N3
IRCT2014053016465N3Completed未知

Evaluating effects of omega-3 supplementation on weight and depression among overweight or obese women with depression compared to placebo

Tehran University of Medical Sciences0 sites50 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 57 years (—)
Sex
Female

Inclusion Criteria

  • •Age 18 to 50 years; females; Body Mass Index above 25; patients with mild (minor) depression based on semi- structured diagnostic interview by a psychiatrist; to sign a consent form

Exclusion Criteria

  • •Those who are taking antidepressants; severe (major) depression; psychotic depression or have suicidal thoughts; use of anti-inflammatory glucocorticoids, and steroids; those who take medicines to reduce appetite or weight; those with diabetes who are taking medications or insulin; those with heart disease or hypercholesterolemia who are taking medication (statins, fibrates, diuretics); those how are taking oral anti-inflammatory drugs corticosteroids or any drug that causes weight loss or gain; taking hormonal contraceptives; pregnancy and lactation; menopause; severe mental disorder; schizophrenia and bipolar; hypothyroidism; exercise professionals; allergic to fish (due to Omega-3 supplements); those with special diets such as the diets for kidney disorders.

Investigators

Similar Trials

Evaluating the effects of omega-3 on... | Clinical Trial